BacterioScan
St. Louis, US · Founded 2010 · Delaware corporation
Find your way into BacterioScan
Sign up to see every warm intro you have to BacterioScan
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BacterioScan team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
Founders & leadership

Board
Reported raises · per SEC filings
Form D private placements$7.4M disclosed across 2 rounds · 2013–2015
▶$1.7MraisedAug 2015 · 7 investors · Other TechnologyRule 506(b)
- Richard R. VietorDirector
- Greg HewettDirector
- Moshe BarkanDirector
- Michael E. ThamanExecutive Officer, Director
- Dana MarshallExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.7M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedFeb 2015 · 7 investors · BiotechnologyRule 506(b)
- Michael E. ThamanDirector
- Amnon WeischelbaumDirector
- Richard R. VietorDirector
- James Brigham, Jr.Director
- William R. MarshallDirector
- Dana A. MarshallExecutive Officer
- Moshe BarkenDirector
- Rhonda SoestExecutive Officer
- Offering amount
- $6M
- Amount sold
- $5.7M
- Minimum investment
- $150K
- First sale
- May 2013
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as BacterioScan.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $210.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does BacterioScan do?
- Bacterioscan develops diagnostic technologies and solutions for bacterial detection and identification. The company serves healthcare, pharmaceutical, and diagnostics markets.
- How much funding has BacterioScan raised?
- BacterioScan has disclosed $7.4M raised across 2 rounds.
- Where is BacterioScan headquartered?
- BacterioScan is headquartered in St. Louis, US.
